Drug recall · June 15, 2022
Alprostadil Injection USP 500 mcg/mL recall
Why: Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01
- Lots / codes
Lot #:100022404, Exp Date 10/2022; Lot #:100023333, Exp Dat 12/2022
- Quantity
- 3109 cartons
- Company
- Teva Pharmaceuticals USA Inc, Parsippany, NJ
- Distribution
- Product was distributed nationwide in the US Market
- Initiated
- May 18, 2022 · Voluntary: Firm initiated
- Classified
- June 7, 2022
- Reported
- June 15, 2022
- Ended
- December 8, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprostadil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.